Stent for Life Initiative placed at the forefront in Egypt 2011.
OBJECTIVE
Myocardial infarction is a medical emergency in which 25 to 35% of patients will die before receiving medical attention. The Stent for Life registry was launched to access the current situation of the Egyptian population presenting with STEMI, and to determine what were the barriers to providing patients with cardiac problems appropriate care.


RESULTS
This registry was conducted at 14 centres covered all the Egyptian regions including 1,324 consecutive patients presenting with STEMI during the period between January 1st, 2011 to November, 2011. Fourteen centres and 38 interventionalists participated in this registry; only six centres are Pilot Centres (fulfilling the criteria for a primary PCI centre) and were assigned at the end of 2011. Cardiovascular risk factors were mainly smoking (60.5%), dyslipidaemia (46.0%), diabetes (51.4%) and hypertension (56.0%). The mean age at presentation was 56.01±10.61years and 75.0% were male. Only 5% of the STEMI patients arrived via the emergency medical system. Thrombus aspiration was done in 42.7% of patients in primary PCI group and 25.9% in rescue PCI group. Bare metal stents (BMS) were used in 80.7% of the stented patients while drug eluting stents (DES) were used in 19.3% of the stented patients. In-hospital mortality was 2.9% (1.4% in primary PCI group, 1.1% in patients treated with thrombolysis and 0.4% in patients receiving no reperfusion therapy).


CONCLUSIONS
Despite the logistical difficulties, excellent outcomes for acute interventional reperfusion strategy in STEMI can be achieved in our country, possibly similar to those seen in the West. There is a strong need for making the practice of PCI in STEMI more widespread in developing regions.
Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Mohamed
M
Sobhy
Mohamed
M
Sadaka
Nireen
N
Okasha
El Sayed
el S
Farag
Ayman
A
Saleh
Hussein
H
Ismail
Mohamed
M
El Seteiha
Hany
H
Ragy
Mohamed Abdel
MA
Hameed
Radwa
R
Mehanna
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019033:Delivery of Health Care, Integrated / Q000458:organization & administration* / Q000592:standards; D054855:Drug-Eluting Stents; D004534:Egypt; D005260:Female; D006297:Health Services Accessibility / Q000458:organization & administration* / Q000592:standards; D017052:Hospital Mortality; D006752:Hospital Planning / Q000458:organization & administration* / Q000592:standards; D006801:Humans; D008297:Male; D008670:Metals; D008875:Middle Aged; D017146:Models, Organizational; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D009937:Organizational Objectives; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality / Q000592:standards; D017410:Practice Guidelines as Topic; D016730:Program Development; D015397:Program Evaluation; D011474:Prosthesis Design; D012042:Registries; D012307:Risk Factors; D015607:Stents / Q000592:standards; D013997:Time Factors; D061665:Time-to-Treatment / Q000458:organization & administration; D016896:Treatment Outcome; D055815:Young Adult
D008670:Metals